Promoter Preeti Thakkar sold 11.65 lakh shares of Fermenta Biotech for ₹55.34 Cr at ₹474.65 apiece through a market sale, reducing her stake from 7.61% to 3.65%.
A pharmaceutical manufacturer established in 1951, Fermenta Biotech produces active pharmaceutical ingredients, aquaculture chlorine products, biotechnology formulations, and nutraceutical supplements for healthcare applications. The company operates across multiple segments within the pharmaceutical and healthcare sectors, serving both domestic and international markets with a diversified product range. Its portfolio spans traditional pharmaceuticals to specialized biotechnology solutions and wellness products.
Get the next move the moment it happens.
Follow the investors and Fermenta Biotech Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
